The Global Molecular Diagnostics Market is projected to grow with rising technological developments in molecular diagnostic techniques. These advancements are intended to offer higher accuracy, cost-effectiveness, and portability which further drives the market. This information was published by Fortune Business Insights in a report, titled “Molecular Diagnostics Market Size, Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025” offering insights on factors influencing growth.
The global market covered a value of US$ 8012.7 Mn in the year 2017 and is projected to reach US$ 13873.6 Mn by 2025. As per the report, the global market is expected to garner a healthy CAGR of 7.1% throughout the forecast period.
Request Sample PDF:
Infectious Diseases: The Largest Growing Segment Among Other Applications
Among applications, infectious diseases segment is expected to account for a majority of share in the global molecular diagnostic market. The scope of this segment is increasing owing to the rising number of patients suffering from infections and microbial outbreaks. Moreover, the infectious diseases segment covered a share of 60% in the year 2017. Development of tests for several diseases and rising awareness about the benefits of adopting molecular diagnostic technologies may prevent the occurrence of infectious diseases.
Global organizations such as World Bank and the World Health Organization (WHO) are planning to conduct awareness programs to increase the talent pool for molecular diagnostics. Adoption of molecular diagnostic systems is rising among end-users such as clinics, hospitals, emergency centers, and pathology labs.
North America Continues to Maintain Its Stronghold until 2025
“Well-established healthcare infrastructure, combined with the rising incidence of cancer is helping the market grow in North America,” stated a lead analyst at Fortune Business Insights. “Developed healthcare systems further helps in the easy availability and accessibility of advanced instruments such as molecular diagnostics. In 2017, this regional market was valued at US$ 3639.4 Mn and is likely to lead the global landscape through the forecast period. The rising collaborations and association between research hospitals and academic institutions encourages growth of the market in this region. Both the bodies are involving in continuous discussions for process improvements in molecular diagnosis.
The market in Europe is also expected to witness considerable growth with growing emphasis on clinical microbiology and hospital research organizations. This is mainly done to increase the number of molecular diagnostic techniques. Rapidly developing healthcare infrastructure and rising investments in research and development activities are factors responsible for creating good growth opportunities.
Browse Complete Report Details:
Transformation in Healthcare May Lead to Innovative Molecular Diagnostic Systems
The evolution of molecular diagnosis over the years has given birth to different molecular diagnostic tests. These tests help to detect specific RNA or DNA sequences. In addition to this, they help to get an understanding if these sequences are associated with diseases or not. With the rapid transformation of healthcare, innovative molecular diagnostic tests are likely to introduce in the coming years.
This will further transform the molecular biology field. Other factors driving the molecular diagnostic market are rising demand for healthcare facilities and personalized medicine. Furthermore, several favourable policies by governments with an aim to encourage care diagnosis and increase awareness about diagnostic procedures drives the market.
Lack of Experts to Conduct Molecular Diagnostic Tests May Hamper the Growth
Although the market is growing at a rapid pace, there are certain factors that may restrict the growth. The molecular diagnostic tests are expensive, which makes it difficult for people with low-income groups to afford these tests. Also, lack of experts to handle such instruments especially in developing countries may impede the growth to some extent. However, with the advent of advanced technology, introduction of new molecular diagnostic systems may help to overcome such challenges.
Abbott Launched a Next Generation System Used for Molecular Diagnosis
The global molecular diagnostics market is expected to be dominated by companies such as Danaher, Abbott, QIAGEN, and F. Hoffmann-La Roche Ltd. Strong supply chain network, rising research and development (R&D) activities, and development strategies are likely to create growth opportunities for the above companies. In 2016, Abbott announced the introduction of a next-generation system called Alinity. This system is used for plasma and blood screening, haematology procedures, molecular diagnostics, and clinical chemistry.
Companies are focussing on to develop new molecular diagnostic tests, which may foster growth of the market. In 2018, Banyan Biomakers received marketing authorization from the U.S. FDA on its first blood diagnostic test. This test was developed to treat traumatic brain injuries which is also referred to as concussion among adults. These developments are likely to have a positive impact on the overall market.
Speak to Analyst:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245